Allergan To Report Q4 Tuesday As Business Fattens
Allergan (AGN) is set to report its Q4 results before the open Tuesday,as it digests a couple of acquisitions aimed at kick-starting its growth. Analysts polled by Thomson Reuters expect profit of $1.18 a share, up 18% from the year-earlier quarter, with sales rising 7.5% to $1.51 billion. The company's stock has been trading near record highs for the last couple weeks, since it announced it's buying Map Pharmaceuticals (MAPP) for $958 million.
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here